From Surf Wiki (app.surf) — the open knowledge base
Renal artery stenosis
Kidney disease
Kidney disease
| Field | Value |
|---|---|
| name | Renal artery stenosis |
| image | Kidney PioM.png |
| caption | |
| risks | Smoking, High blood pressure |
| diagnosis | Captopril challenge test, Doppler ultrasound |
| treatment | ACE inhibitors |
| field | Nephrology |
|
Renal artery stenosis (RAS) is the narrowing of one or both of the renal arteries, most often caused by atherosclerosis or fibromuscular dysplasia. This narrowing of the renal artery can impede blood flow to the target kidney, resulting in renovascular hypertension – a secondary type of high blood pressure. Possible complications of renal artery stenosis are chronic kidney disease and coronary artery disease.
Signs and symptoms
Most cases of renal artery stenosis are asymptomatic, and the main problem is high blood pressure that cannot be controlled with medication. Decreased kidney function may develop if both kidneys do not receive adequate blood flow, furthermore some people with renal artery stenosis present with episodes of flash pulmonary edema.
Cause
Renal artery stenosis is most often caused by atherosclerosis which causes the renal arteries to harden and narrow due to the build-up of plaque. This is known as atherosclerotic renovascular disease, which accounts for about 90% of cases. This narrowing of renal arteries due to plaque build-up leads to higher blood pressure within the artery and decreased blood flow to the kidney. This decreased blood flow leads to decreased blood pressure in the kidney, which leads to the activation of the Renin-Angiotensin-Aldosterone (RAA) system. Juxtaglomerular cells secrete renin, which converts angiotensinogen to angiotensin I, which is then converted to angiotensin II by angiotensin converting enzyme (ACE). Angiotensin II then acts on the adrenal cortex to increase secretion of the hormone aldosterone. Aldosterone causes sodium and water retention, leading to an increase in blood volume and blood pressure. Therefore, people with RAS have chronic high blood pressure because their RAA system is hyperactivated.
Pathophysiology
The pathophysiology of renal artery stenosis leads to changes in the structure of the kidney that are most noticeable in the tubular tissue.
Changes include:
- Fibrosis
- Tubular cell size (decrease)
- Thickening of Bowman capsule
- Tubulosclerosis
- Glomerular capillary tuft (atrophy)
Diagnosis
The diagnosis of renal artery stenosis can use many techniques to determine if the condition is present, a clinical prediction rule is available to guide diagnosis.
Among the diagnostic techniques are:
- Doppler ultrasound study of the kidneys
- Refractory hypertension
- Auscultation (with stethoscope) - bruit ("rushing" sound)
- Captopril challenge test
- Captopril test dose effect on the differential renal function as measured by MAG3 scan.
- Renal artery arteriogram.
The specific criteria for renal artery stenosis on Doppler are an acceleration time of greater than 70 milliseconds, an acceleration index of less than 300 cm/sec² and a velocity ratio of the renal artery to aorta of greater than 3.5.
Treatment
Atherosclerotic renal artery stenosis
It is initially treated with medications, including diuretics, and medications for blood pressure control. It is a relatively safe procedure.
Stenting vs. medical therapy
Historically, balloon dilation of vascular lesions was first performed in 1964. The first treatment of renovascular lesions by percutaneous catheter angioplasty (PTA) was performed in 1978 by Andreas Roland Grüntzig. Stenting became the standard of endovascular care for ostial stenoses because of the poor technical success of PTA. The use of renal artery stents, particularly for ostial lesions, has further improved long-term patency rates. Further research into the efficacy of renal artery stenting has since been conducted, including the ASTRAL and CORAL trials, and research is ongoing as to whether there is a clear benefit to stenting over more conservative management, such as by medications alone.
The ASTRAL trial randomized 806 patients to renal artery revascularization via stenting versus medical therapy, with the following results:
- No survival advantage in the stented group
- No benefit for renal function in the stented group
- Serious complications with stenting (2 deaths, 3 amputations, others)
The CORAL study randomized 947 patients to stenting versus medical therapy, with a primary endpoint of major cardiovascular or renal events. Similarly, this study also found there was no benefit to stenting over medical treatment alone.
Collectively, the evidence so far does not support renal artery stenting as a proper mainstay treatment for stenosis because it conveys no survival benefit, no true renoprotection, and does not decrease the need for antihypertensive medications. A debate remains about whether or not it is beneficial to stent for purely ostial lesions, and comparing the success in treating with angioplasty (such as balloon dilatation) versus stenting. Smoking cessation and thoughtful blood pressure control, via lifestyle/dietary changes and medication, are the current mainstays of managing renovascular hypertension.
Fibromuscular dysplasia
Angioplasty alone is preferred in fibromuscular dysplasia, with stenting reserved for unsuccessful angioplasty or complications such as dissection.
References
References
- "Renal Artery Stenosis".
- {{MedlinePlusEncyclopedia. 000204. Renovascular hypertension
- (2 September 2011). "Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering Syndrome". European Heart Journal.
- (2017). "Atherosclerotic renovascular disease – epidemiology, treatment and current challenges". Advances in Interventional Cardiology.
- (March 2021). "Renal artery stenosis". Progress in Cardiovascular Diseases.
- {{EMedicine. article. 245023. Renal Artery Stenosis
- Steyerberg, Ewout. (16 December 2008). "Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating". Springer Science & Business Media.
- (December 2009). "Doppler ultrasound and renal artery stenosis: An overview". Journal of Ultrasound.
- (November 2013). "Renal Artery Stenosis in Patients With Resistant Hypertension". The American Journal of Cardiology.
- (20 September 2013). "Clinical Examination: A Systematic Guide to Physical Diagnosis". Elsevier Health Sciences.
- Ong, Yong Yau. (1 January 2005). "A Clinical Approach to Medicine". World Scientific.
- (May 2014). "Radionuclides in Nephrourology, Part 2: Pitfalls and Diagnostic Applications". Journal of Nuclear Medicine.
- Sam, Amir H.. (2010). "Rapid Medicine". [[Wiley-Blackwell]].
- (December 2011). "Assessment of the kidneys: magnetic resonance angiography, perfusion and diffusion". Journal of Cardiovascular Magnetic Resonance.
- (5 December 2014). "Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis". Cochrane Database of Systematic Reviews.
- (8 April 2009). "Pediatric Solid Organ Transplantation". John Wiley & Sons.
- (May 2001). "Endovascular revascularization of renal artery stenosis: technical and clinical results". Journal of Vascular Surgery.
- null, null. (2009-11-12). "Revascularization versus Medical Therapy for Renal-Artery Stenosis". New England Journal of Medicine.
- (2014-01-02). "Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis". New England Journal of Medicine.
- (February 2014). "Treatment of hypertension in patients with renal artery stenosis due to fibromuscular dysplasia of the renal arteries". Cardiovascular Diagnosis and Therapy.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Renal artery stenosis — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report